Comparison of cryoplasty and conventional angioplasty for treating stenotic-occlusive lesions of the femoropopliteal arteries in diabetic patients: immediate, mid-term and long-term results

Fossaceca, Rita; Guzzardi, Giuseppe; Terlizzi, M. Di; Divenuto, Ignazio; Malatesta, Emanuele; Cerini, Paolo; Cusaro, C; Carriero, Alessandro

doi:10.1007/s11547-012-0793-7

Cited by 13 publications

(5 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These authors showed positive results combining the effect of nitinol self-expanding stent placement and posterior cryoplasty treatment in superficial femoral arteries. Another randomised study reported similar conclusions from a cohort of diabetic patients who underwent a single cryoplasty treatment, showing better results than PTA in the immediate, short and long-term in the femoropopliteal arteries [8]. However, in other randomised studies of femoropopliteal lesions, cryoplasty and PTA had the same TLR at mid-term [9][10][11], failing to demonstrate an overwhelming benefit of cryoplasty over PTA.…”

Section: Introductionmentioning

confidence: 85%

Cryoplasty versus angioplasty in the treatment of arterial restenosis in an experimental model of atherosclerosis in rabbits

et al. 2015

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 85%

Cryoplasty versus angioplasty in the treatment of arterial restenosis in an experimental model of atherosclerosis in rabbits

et al. 2015

View full text Add to dashboard Cite

“…Long-term results from a single-center controlled trial of 50 patients with diabetes and femoropopliteal disease comparing cryoplasty to PTA also found lower primary patency and higher clinically driven reintervention in the cryoplasty group [113]. Further evidence supports the lack of efficacy specifically in the diabetic population -a small trial of 48 insulin-dependent diabetic patients randomized to cryoplasty or PTA demonstrated that conventional PTA had a superior technical success and decreased restenosis at 6 months compared with cryoplasty [114].…”

Section: Brachytherapymentioning

confidence: 94%

Endovascular therapy for critical limb ischemia

Domínguez

Bahadorani

Reeves

et al. 2015

Expert Review of Cardiovascular Therapy

View full text Add to dashboard Cite

Critical limb ischemia (CLI) represents an advanced disease state of peripheral arterial disease. It manifests as lower extremity ischemic rest pain or ischemic skin lesions leading to ulceration or gangrene. Patients with CLI often have multiple medical comorbidities and a 1-year mortality rate of 25% and a 1-year amputation rate of 25%. Historically, bypass surgery with autogenous veins for flow restoration has been the first-line therapy for CLI. However, advances in endovascular techniques and device technology have changed the treatment paradigm. Catheter-based technologies are rapidly evolving at a rate that is outpacing large-scale studies evaluating relevant clinical outcomes. Patients with CLI require a multidisciplinary management approach centered on aggressive medical therapies, wound care and prompt revascularization, with an emphasis on limb salvage. This review summarizes the contemporary endovascular therapies including balloon angioplasty, atherectomy and bare-metal stenting. In addition, we review emerging technologies, such as drug-eluting stents, drug-coated balloons and chronic total occlusion recanalization devices.

show abstract

“…In all, 2640 publications were screened; ultimately 53 articles 7–59 (45 trials comprising a total of 5565 patients) were selected according to the guidelines in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, 60 as illustrated in Figure 1. The baseline demographic data for all the RCTs are detailed in Table 1.…”

Section: Methodsmentioning

confidence: 99%

“…All-cause mortality. Twenty-seven studies 8,11,12,14,18,19,[24][25][26]28,30,32,33,35,[37][38][39][40]43,45,47,48,[50][51][52]56,58 (4080 patients) contributed to the network plot of 12-month mortality presented in Figure 2. BA-BR (OR 0.16, 95% CI The results of the predictive interval plot for the 12-month all-cause mortality network are presented in Figure 3A Figure 1) had no significant visual asymmetry and the Egger's test (p>0.72) together suggested no publication bias.…”

Section: Binary Restenosis At 24mentioning

confidence: 99%

Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials

et al. 2020

View full text Add to dashboard Cite

Purpose: To report the results of a network meta-analysis of randomized controlled trials (RCTs) comparing multiple endovascular treatments for de novo femoropopliteal lesions. Materials and Methods: The MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials databases were systematically searched on June 1, 2019, for prospective RCTs comparing 14 treatments [ie, atherectomy, brachytherapy, cryoplasty, cutting balloons, drug-coated balloons, bare nitinol stents, drug-eluting stents (DES), covered stents (CS), and combinations] in the treatment of de novo femoropopliteal lesions. Outcomes were technical success; binary restenosis and target lesion revascularization (TLR) at 6, 12, and/or 24 months; and all-cause mortality at 12 months. Ultimately, 53 articles reporting on 45 studies (91 study arms; 5565 patients) were selected. For the technical success outcome, all types of stents, all balloons, and all atherectomy devices were aggregated in stent, balloon, and atherectomy technology groups, respectively. Results: In terms of technical success for aggregated treatment types, stent technology was the most effective treatment and was better than balloon and atherectomy technologies. In terms of binary restenosis, DES was the most effective single treatment at the 6- and 12-month follow-up and CS at the 24-month follow-up. Both DES and CS were better than the majority of other single treatments, including balloon angioplasty, cutting balloon, cryoplasty, directional atherectomy, and bare nitinol stent during all follow-up periods. In terms of TLR, DES was the second most effective single treatment and the most effective single treatment at the 6- and 12-month follow-up intervals; CS was the most effective single treatment at the 24-month follow-up. Both DES and CS were better than the majority of other single treatments. The 12-month all-cause mortality of both DES and CS were similar to other treatments, whereas cryoplasty seemed to be the least effective treatment with regard to binary restenosis and TLR. Conclusion: Both DES and CS had substantial advantages in terms of restenosis and TLR in femoropopliteal lesions and were similar to aggregate stent technology in terms of technical success. DES performed better within 12 months after operation and CS at ~24 months, but neither had much advantage in terms of mortality. In contrast, cryoplasty seemed to be a less effective treatment.

show abstract

Comparison of cryoplasty and conventional angioplasty for treating stenotic-occlusive lesions of the femoropopliteal arteries in diabetic patients: immediate, mid-term and long-term results

Abstract: Conventional angioplasty is more effective than cryoplasty for treating stenotic-occlusive lesions of the femoropopliteal arteries in diabetic patients and provides better immediate, mid-term and long-term results.

Cited by 13 publications

References 26 publications

Cryoplasty versus angioplasty in the treatment of arterial restenosis in an experimental model of atherosclerosis in rabbits

Cryoplasty versus angioplasty in the treatment of arterial restenosis in an experimental model of atherosclerosis in rabbits

Endovascular therapy for critical limb ischemia

Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials

Contact Info

Product

Resources

About